Company Filing History:
1 out of 11 
1 out of 489 
Years Active: 2014
Title: The Innovative Work of Cornelia Theunissen
Introduction: Cornelia Theunissen, a distinguished inventor from Gwynedd, GB, has made significant contributions to the field of vaccination with her innovative research and patent. Her work primarily focuses on the development of adjuvants that enhance vaccine efficacy, showcasing her commitment to advancing public health.
Latest Patents: Theunissen holds a notable patent for "Adjuvants for use in vaccination". The patent describes a compound with a complex formula that states the composition involves various optionally-substituted moieties, such as alkyl, alkenyl, and aryl groups. This innovative formulation aims to improve the effectiveness of vaccines by enhancing the immune response, which is crucial for effective immunization strategies.
Career Highlights: Throughout her career, Cornelia Theunissen has worked with prominent research institutions, notably Bangor University and Universiteit Gent. Her contributions to vaccine formulation have positioned her as an influential figure in the scientific community, tackling some of the most pressing health challenges.
Collaborations: Cornelia has collaborated with esteemed colleagues, including Mark Stephen Baird and Juma'a Raheem Najeem Al-Dulayymi. These partnerships have fostered a rich environment for innovation and have played a vital role in her research journey, allowing for the exchange of ideas and expertise.
Conclusion: Cornelia Theunissen is a testament to the impact that dedicated inventors can have on healthcare through innovative solutions. Her patent for adjuvants in vaccination not only highlights her ingenuity but also reflects the importance of collaboration within the scientific community. With her ongoing contributions, Theunissen continues to inspire future generations of inventors and researchers alike.